SHERIDAN, WYOMING - December 16, 2025 - Advita Ortho has been recognized with an Innovation award in the 2025 Medical Device Network Excellence Awards for its Newton® Balancing Technology, highlighting the growing clinical and commercial demand for more data-driven, reproducible approaches to soft-tissue management in total knee replacement surgery.
Award recognition spotlights soft-tissue balancing as a key outcomes lever
While implant design and alignment remain central to knee arthroplasty performance, soft-tissue balancing is increasingly viewed as a differentiator in patient satisfaction and functional outcomes. Advita Ortho is positioning Newton as a method to bring greater consistency to what has often been a highly surgeon-dependent step-an area the company notes has historically contributed to dissatisfaction in a meaningful share of procedures.
"We are thrilled to be recognized for our Newton Balancing Technology, which represents Advita Ortho's commitment to patient-centered innovation," said Aurelio Sahagun, CEO of Advita Ortho. "By transforming the technologies surgeons use to approach soft tissue management, we're helping make knee replacement outcomes more predictable and more reliable for patients everywhere. This award validates the hard work of our team and sets the tone for the next chapter of Advita Ortho, delivering intelligent solutions that empower surgeons and advance lives."
How Newton aims to standardize a traditionally subjective step
Newton is designed to deliver ligament-driven balance by combining a force-controlled intra-articular tensioner with the company's GPS platform. Advita Ortho says the approach provides dynamic soft tissue analytics, pre-resection insights, and full-range personalized planning-supporting surgeons in translating plans into consistent execution across the full arc of motion.
At the workflow level, the proposition is straightforward: convert soft-tissue assessment from manual "feel" to measurable parameters that can be repeated across cases, teams, and sites of care.
Real-time ligament laxity measurement and intraoperative decision support
At the core of Newton's positioning is its ability to measure real-time ligament laxity under controlled tension. By applying a controlled force through range of motion, the system is intended to isolate ligament behavior and reduce variability that can occur with manual methods. Integrated with GPS, the system displays real-time gaps that can inform intraoperative decisions tied to implant size, alignment, placement, and soft tissue balance.
For hospitals and ASCs focused on predictable outcomes and reduced variability, technologies that standardize intraoperative decision points can support quality initiatives-particularly when surgeon technique variance is a recognized operational challenge.
Evidence base and adoption implications for providers and ASC settings
Advita Ortho points to "more than 50 publications and scientific presentations" supporting Newton's performance versus conventional methods, citing advantages such as higher reliability independent of surgeon experience and improved gap balancing. The company also references peer-reviewed work including a cadaveric study in the Journal of Experimental Orthopaedics and additional studies in the Journal of Orthopaedics and The Journal of Arthroplasty tied to improved patient-reported outcome measures when transitioning to Newton.
From a buyer perspective, the most relevant questions typically shift from "does it work" to "can it scale" across service lines-covering training burden, workflow disruption, and whether consistent balancing can reduce rework, improve patient satisfaction metrics, and strengthen orthopedic program competitiveness.
Strategic differentiation versus capital-heavy robotic platforms
Advita Ortho is also positioning Newton as a practical alternative for sites that want data-rich planning without the capital investment and annual maintenance burden commonly associated with competing robotic platforms. The company describes Newton as compact and ASC-friendly, radiation-free, and foundational for future AI-powered workflows beyond knee arthroplasty-an angle likely aimed at administrators evaluating technology roadmaps under tightening budgets.
For full product information on Newton, visit www.advita.com/AI.